RxDoctor Payments Data

George Baxter

Adult Health · Seattle, WANPI 1649433251

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $696,862 of the $868,105 with a category attached, or 80.3%. Galderma Laboratories, L.p. accounts for 88.3% of it on its own, with 3 other manufacturers making up the rest. Among adult health clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$868,105in general payments, 2019–2025

Across 1,230 payments — averaging $705.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$766K
  • AbbVie$102K
  • Merz North America, Inc.$100
  • Revance Therapeutics, Inc.$94

What the payments were for

  • Consulting fees$49,2416%
  • Speaking & faculty fees$696,86280%
  • Travel & lodging$99,06211%
  • Food & beverage$22,9403%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Galderma Laboratories, L.p.940$766,319
AbbVie(2 entities)286$101,592
Merz North America, Inc.1$100
Revance Therapeutics, Inc.3$94

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$868,105 in reported general payments places this provider in the 95th percentile of 252 adult health providers in Washington.

See all adult health providers in Washington →

Other adult health in Seattle

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →